文献速递衰弱、肌少症与跌倒老年综合评估

肌少症各组分对预测不良结局的累积与增量价值

Cumulative and Incremental Value of Sarcopenia Components on Predicting Adverse Outcomes.
PubMed 文献 · J Am Med Dir Assoc · 2020-08-05

结果显示在SARC-F基础上增加握力和步速评估可显著提高多数结局的预测AUC,而进一步用DXA测ASM无额外预测价值。

要点

  • 在SARC-F基础上加握力、步速或5次坐立试验可显著提高多数不良结局的预测AUC。
  • 同时评估握力和步速时多数模型AUC最高(0.539-0.770),除反复跌倒外均显著提升。
  • 在已评估肌力和功能后,加测DXA的ASM除2种情况外未显著提高AUC。

核心结论

  • 在SARC-F基础上评估肌力和身体功能可增加对不良结局的预测能力,而进一步用DXA测ASM无额外预测价值。

主要发现

  • 在SARC-F基础上,评估握力、步速或5次坐立试验可显著提高大多数不良结局的AUC。
  • 同时评估握力和步速在多数预测模型中AUC最高(0.539-0.770),除反复跌倒外所有结局AUC显著提高。
  • 在已评估肌力和功能后,加测ASM除2种情况外未显著提高AUC。
  • 在女性中,身高调整ASM较高与躯体功能受限加重风险较高相关(OR 1.25,95%CI 1.12-1.40)。
  • 在女性中,身高调整ASM较高与躯体生活质量下降风险较高相关(OR 1.18,95%CI 1.06-1.33)。

临床怎么用

  • 社区老年肌少症风险评估可优先采用SARC-F联合握力和步速评估,无需常规加测DXA的ASM来提升预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the incremental value of sarcopenia components, following the diagnosis algorithm of the Asian consensus, on predicting adverse outcomes. DESIGN: A prospective cohort study. SETTING AND PARTICIPANTS: Four thousand community-dwelling Chinese adults (2000 men) aged 65 years or older in Hong Kong (mean age = 72.5 ± 5.2). METHODS: SARC-F was used as the initial predictor of 9 adverse outcomes. In step 2, muscle strength (ie, grip strength) and/or functions (ie, chair-stand, walking speed) were added on top of SARC-F. In step 3, height-, weight-, and body mass index-adjusted appendicular skeletal mass (ASM) measured by dual-energy x-ray absorptiometry (DXA) were added separately to all models formulated in step 2. The areas under the receiver operating characteristic curve (AUCs) were calculated for the models formulated in all steps. Each cumulative AUC would be compared with the AUC yielded in the previous step to evaluate the incremental prediction value. RESULTS: On top of SARC-F, assessing grip strength, walking speed, or 5-time chair-stand significantly increased the AUC for most adverse outcomes. In particular, assessing both grip strength and gait speed yielded the highest AUC in most prediction models (AUC = 0.539-0.770) and significantly increased the AUC for all outcomes except for recurrent falls. With both muscle strength and function assessed, adding ASM failed to significantly increase the AUC except for 2 conditions. In the 2 conditions, however, a higher height-adjusted ASM was associated with a higher risk of having worsened physical limitations [OR 1.25, 95% confidence interval (CI) 1.12-1.40] and decline in the physical quality of life (OR 1.18, 95% CI 1.06-1.33) in women. CONCLUSIONS AND IMPLICATIONS: Assessing muscle strength and function provides additional power to predict adverse outcomes on top of SARC-F. Further assessment of muscle mass with DXA provides no extra constructive value ito bettering the prediction regardless of the adjustment parameters. Alternative technologies to measure muscle mass might be required.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Lam FMH, Su Y, Lu ZH, et al. Cumulative and Incremental Value of Sarcopenia Components on Predicting Adverse Outcomes. J Am Med Dir Assoc. 2020. PMID: 32768375. doi:10.1016/j.jamda.2020.05.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。